Cargando…
Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer
Human high-mobility group A2 (HMGA2) encodes for a non-histone chromatin protein which influences a variety of biological processes, including the cell cycle process, apoptosis, the DNA damage repair process, and epithelial–mesenchymal transition. The accumulated evidence suggests that high expressi...
Autores principales: | Huang, Yu-Min, Cheng, Chia-Hsiung, Pan, Shiow-Lin, Yang, Pei-Ming, Lin, Ding-Yen, Lee, Kuen-Haur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920845/ https://www.ncbi.nlm.nih.gov/pubmed/31684108 http://dx.doi.org/10.3390/biom9110688 |
Ejemplares similares
-
Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer
por: Chang, Hsin-Yi, et al.
Publicado: (2017) -
Topical Ciclopirox Olamine 1%: Revisiting a Unique Antifungal
por: Sonthalia, Sidharth, et al.
Publicado: (2019) -
Synthetic Derivatives of Ciclopirox are Effective
Inhibitors of Cryptococcus neoformans
por: Lin, Jeffrey, et al.
Publicado: (2021) -
Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models
por: Mihailidou, Chrysovalantou, et al.
Publicado: (2017) -
Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum
por: Monti, Daniela, et al.
Publicado: (2019)